Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

125.14 +3.66 (+3.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,008,618
Open 122.76
Bid (Size) 125.55 (2)
Ask (Size) 125.92 (1)
Prev. Close 121.48
Today's Range 120.79 - 127.20
52wk Range 62.55 - 170.47
Shares Outstanding 383,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Biotech Stocks to Buy in Case of Another Pandemic
These are three of the best biotech stocks to keep an eye on as the industry helps governments prepare for the next pandemic. 
Via InvestorPlace
Moderna, Regeneron Pharmaceuticals And 2 Other Stocks Insiders Are Selling
Via Benzinga

Performance

YTD
+11.24%
+11.24%
1 Month
-9.25%
-9.25%
3 Month
+20.57%
+20.57%
6 Month
+22.49%
+22.49%
1 Year
+2.07%
+2.07%

More News

Read More
2 Growth Stocks Down 25% to Buy Right Now
Via The Motley Fool
Is Moderna Stock a Buy?
Via The Motley Fool
Health Officials Keep Close Eye On Bird Flu As It Infects Cows For The First Time
Via Benzinga
Unpacking the Latest Options Trading Trends in Moderna
Via Benzinga
Unpacking the Latest Options Trading Trends in Moderna
Via Benzinga
Here's How Much $1000 Invested In Moderna 5 Years Ago Would Be Worth Today
Via Benzinga
3 Pharma Stocks That Could Make Your Grandchildren Rich
Via InvestorPlace
Investor That Backed Moderna Raises $3.6B For AI-driven Biotech Ventures
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024
Via ACCESSWIRE
Moderna To Collaborate With Mitsubishi On Respiratory Vaccine Promotion In Japan
Via Benzinga
Moderna And Mitsubishi Tanabe Pharma Corporation Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Japan, Including COVID-19 Vaccines
Via ACCESSWIRE
3 Healthcare Stocks to Sell in July Before They Crash & Burn
Via InvestorPlace
The 3 Best Gene Editing Stocks to Buy in July 2024
Via InvestorPlace
3 Biotech Stocks to Sell in July Before They Crash & Burn
Via InvestorPlace
3 Biotech Stocks Turning DNA Dreams Into Dollars
Via InvestorPlace
AI Has 'The Hallmarks Of An Inflating Bubble,' Warns Veteran Wall Street Investor
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
What's Going On With Moderna Stock Wednesday
Via Benzinga
mRNA Technology Promises To Make A Long-Time Coming Turning Point In Cancer Treatment
Via Benzinga
Exposures COVID-19
London High Court Ruling Fuels Pfizer And Moderna Legal Dispute Over COVID-19 Vaccine Patents
Via Benzinga
Topics Intellectual Property
Exposures COVID-19 Intellectual Property
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Via MarketBeat
Topics ETFs
Exposures COVID-19
Amid Rapidly Rising Bird Flu Cases, Moderna Lands $176M Worth US Government Contract For Vaccine
Via Benzinga
Moderna Receives Project Award through BARDA's Rapid Response Partnership Vehicle Consortium to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
Via ACCESSWIRE
Surprise! 3 Stocks That Are Outperforming Nvidia in 2024.
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.